JPMorgan Chase & Co. Lowers Afya (NASDAQ:AFYA) Price Target to $20.50

Afya (NASDAQ:AFYA) had its target price decreased by research analysts at JPMorgan Chase & Co. from $25.00 to $20.50 in a report released on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 30.41% from the company’s previous close.

Separately, The Goldman Sachs Group began coverage on Afya in a research note on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price objective for the company. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $19.60.

Afya Price Performance

Afya stock traded up $0.07 during trading on Friday, reaching $15.72. The company had a trading volume of 5,107 shares, compared to its average volume of 76,089. The firm’s 50-day simple moving average is $16.01 and its 200 day simple moving average is $16.76. Afya has a 52 week low of $14.52 and a 52 week high of $22.48. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.60 and a quick ratio of 1.60.

Hedge Funds Weigh In On Afya

Several large investors have recently made changes to their positions in AFYA. Public Employees Retirement System of Ohio bought a new stake in shares of Afya in the third quarter worth about $34,000. State Street Corp raised its position in shares of Afya by 118.2% during the 3rd quarter. State Street Corp now owns 73,098 shares of the company’s stock valued at $1,248,000 after buying an additional 39,592 shares in the last quarter. Quarry LP bought a new stake in Afya during the third quarter worth approximately $75,000. Point72 Asset Management L.P. bought a new stake in shares of Afya in the 3rd quarter valued at approximately $842,000. Finally, Centiva Capital LP purchased a new stake in Afya during the 3rd quarter valued at $213,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.